Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Nordic Pharma Consulting ApS
APS
Active
Reklamebeskyttelse
CVR 37368598
Ullasvej 7B, 2880
Bagsværd
Business and other management consultancy activities
·
NACE 7020
Est. 2016 · 10 years old
11 employees
Overvåg
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Nordic Pharma Consulting ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
5M
9M
14M
18M
9M
2021
12M
2022
11M
2023
14M
2024
16M
2025
EBITDA
DKK millions
6M
5M
3M
2M
0M
2M
2021
5M
+150%
2022
2M
-60%
2023
4M
+100%
2024
5M
+25%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
8.841
11.622
11.213
14.102
15.902
Staff expenses
-6.470
-6.960
-9.165
-10.289
-11.152
EBITDA
2.371
4.662
2.048
3.813
4.750
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
2.371
4.662
2.048
3.813
4.750
Net financials
-27
-42
7
13
-4
Profit before tax
2.344
4.620
2.055
3.826
4.746
Tax
524
1.025
466
860
1.061
Net profit
1.820
3.595
1.589
2.966
3.685
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
5.053
10.180
5.207
8.146
7.927
Equity
2.623
4.397
2.391
3.769
4.487
Long-term debt
0
0
0
0
0
Short-term debt
2.430
5.783
2.815
4.377
3.440
Total debt
2.430
5.783
2.815
4.377
3.440
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
29.9%
This company
2021
2025
Soliditetsgrad
56.6%
This company
38.2%
Market median
+48% vs market
2021
2025
Egenkapitalforrentning
82.1%
This company
18.4%
Market median
+346% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
23.2%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
2.01×
This company
2021
2025
Gæld/egenkapital
0.77×
This company
0.62×
Market median
+24% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Nordic Pharma Consulting ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
